ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

FDA hits MAQUET with a Class I recall for flawed anesthesia machines

July 6, 2012 1:11 pm by | 0 Comments

FDA warning letter

MAQUET Medical Systems announced Friday that the U.S. Food and Drug Administration has classified its voluntary recall of certain anesthesia machines as a Class I recall.

MAQUET, a subsidiary of the public Swedish firm Getinge Group, instituted a voluntary recall of the C20, C30 and C40 FLOW-i Anesthesia Systems in February because of a software malfunction associated with the MAN/AUTO switch used for changing between manual and automatic ventilation modes, according to a news release. The recall only affects products sold between May 2010and December 2011. The Flow-i C30 model was sold in the U.S. while the C20 and C40 models were sold overseas.

According to one FDA adverse event report on its MAUDE databasethat occurred Nov. 1, the C30 model generated a technical error code showing that the anesthesia machine was delivering lower oxygen than the level at which it was set.

Advertisement

A Class I recall is designated to be the most serious of all recall notifications by the FDA because it describes “a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.

Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.


Related Topics:

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments

Stay Up To Date

Next Story
Alternative to PSA test for prostate cancer nears $1.5M financing target
Close